KNCV Publications 2025

Salazar-Austin N, Cohn S, Nonyane B, Mulder C, Mulatu F, Bayu S, Bizuayehu M, Conradie G, Malhotra A, Phan P, Hernandez Morfin N, Borsboom S, Mitiku P, Fulas D, Tulema M, Golub JE, Chaisson RE, Churchyard G, Bedru A. Effectiveness of a Home-based Approach to Child Contact Investigation and TPT Management by Community Health Workers in Ethiopia: A Pragmatic Cluster-randomized Trial, Clinical Infectious Diseases, May 16, 2025.
Jerene D, van Kalmthout K, Levy J, Alacapa J, Deyanova N, Dube T, Mganga A, Tasca B, Bodganov A, Efo E, Gamazina K, Celine Garfin AM, Kochanov V, Leung A, Madden N, Maraba N, McQuaid CF, Mleoh L, Onjara B, Powers R, Terleiva Y, van Rest J, Gebhard A, Fielding K, Charalambous S. Effect of digital adherence technologies on treatment outcomes in people with drug-susceptible tuberculosis: four pragmatic, cluster-randomised trials. The Lancet. Volume 405, Issue 10485. p1155-1166. April 05, 2025.
Ali S, Rahman NR, Ashraf, Rumman, Naveed A, Ghafoor A, Ali M et al. Comparative Analysis of Culture and Sputum Smear Conversion Timelines and Their Associated Factors in Smokers Versus Non-smokers With Drug-Resistant Tuberculosis. Cureus 17(3): e80704. March 17, 2025.
Biru M, Datiko DG, Jerene D, Yohannes AG, Molla Y, Suarez P, Gebrekiros W, Kassa A, Kassie Y, Dememew ZG. Designing tuberculosis elimination framework through participatory processes in Ethiopia: Results from stakeholders’ discussions. PLOS One. March 10, 2025.
Madden N, Tadesse AW, Leung CL, Gonçalves Tasca B, Alacapa J, van Kalmthout K, Jerene D, Deyanova N, Ndlovu N, Mokone N, Onjare B, et al. Process Evaluation of Pragmatic Cluster-Randomized Trials of Digital Adherence Technologies for Tuberculosis Treatment Support: A Mixed-Method Study in Five Countries. Tropical Medicine and Infectious Disease. 10(3):68. March 6, 2025.
Useni S, Odume B, Tukur M, Chukwu E, Nwokoye N, Ogbudebe C, Chukwuogo O, Osuoji U, Igwetu C, Gordon I, Nongo D, Eneogu R, Ihesie A, Chukwuekezie O, Anyaike C, Diul MY. Comparative analysis of the impact of portable digital X-ray on TB screening in hard-to-reach areas in Nigeria. Public Health Action. 15(1):17-20. March 1, 2025.
Omotayo SA, Chukwuogo O, Ogbudebe C, Egbule D, Opara P, Bot T, Chukwu E, Nwadike P, Gordon I, Ezekhaigbe C, Yakubu A, Odume B. Finding missing TB cases in Northern Nigeria. Public Health Action. 15(1):38-43. March 1, 2025.
Mwanza W, Lutinala M, Mundia K, Klinkenberg E, de Haas P, Kabaso M, Zimba K, Chabala C, Tambatamba B, Angel M, Lungu P, Lishimpi K. Stool-based Xpert testing for diagnosis of TB in children and critically ill adults. Int J Tuberc Lung Dis. 29(2):75-79. Feb 1, 2025.
Garcia-Prats AJ, Garcia-Cremades M, Cox V, Kredo T, Murzabakova T, Myrzaliev B et al. Characteristics of children and adolescents with multidrug-resistant and rifampicin-resistant tuberculosis and their association with treatment outcomes: a systematic review and individual participant data meta-analysis. Lacent Child Adolesc Health. February, 2025.
Pelzer PT, Stuck L, Martinez L, Richards AS, Acuña-Villaorduña C, Aronson NE et al. Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data. Lancet Microbe. February, 2025.
McQuaid CF, Clark RA, White RG, Bakker R, Alexander P, Henry R et al. Estimating the epidemiological and economic impact of providing nutritional care for tuberculosis-affected households across India: a modelling study. Lancet Glob Health. January 14, 2025.
Sumner T, Clark RA, Prys-Jones TO, Bakker R, Churchyard G, White RG. The potential impact of new tuberculosis vaccines on the burden of tuberculosis in people with HIV in South Africa. AIDS 2025.